At the Mount Sinai Health System we have successfully translated many algorithms from concept to testing and clinical care, in ways that have led to financial savings and improved patient outcomes.

In April 2025, the US Food and Drug Administration (FDA) published a roadmap for leveraging new approach methodologies (NAMs), including in silico approaches such as artificial intelligence (AI), to ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...